cropped-IP3VISO16053055.jpg
MD PhD HDR
Responsable de l’équipe VIH, Hépatites virales et co-morbidités: épidémiologie clinique et santé publique / Head of team Multimorbidity and Public Health in Patients with HIV or Hepatitis
Responsable du CMG-EC Inserm-ANRS/ Head of clinical trial unit Inserm-ANRS

Parcours


2015  Habilitation, Ecole Doctorale Scoiétés, Politique, Santé Publique, Speciality: Public Health, University of Bordeaux, France
2010    PhD in Science, Technology and Health, Speciality: Epidemiology and Public Health, University of Bordeaux, Bordeaux, France.
2007   MD, Justus Liebig University, Giessen, Germany.
2007  MSc in Epidemiology and Biostatics, University of Bordeaux, ISPED, Bordeaux, France.
2004  Approbation – German official license to practice as a doctor, Federal State examination board for therapeutic professions – Hessisches Landesprüfungsamt für Heilberufe, Frankfurt am Main, Hessen, Germany.
2003     Certificate of the Medical Examination, Federal State examination board for therapeutic professions – Hessisches Landesprüfungsamt für Heilberufe, Frankfurt am Main, Hessen, Germany.
1997-2003  Medical School, Justus Liebig University, Giessen, Germany and Universidad Autonoma, Madrid, Spain.

Fonctions


Fonctions hospitaliers

Méthodologiste à l’unité de soutien méthodologique à la recherche clinique USMR du CHU de Bordeaux

Fonctions pédagogiques

Responsable de l’UE EPI201 Conception et analyse des études de cohortes (8 ECTS) de la spécialité Epidémiologie du Master de Santé Publique de l’université de Bordeaux

Co-responsable de la commission pédagogique gestion de l’offre de formation de l’Isped

Co-responsable du module Recherche clinique de l’école d’été de l’Isped

Fonctions liées à la recherche

Responsable de l’équipe VIH, Hépatites virales et co-morbidités: épidémiologie clinique et santé publique

Responsable du CMG-EC Inserm-ANRS

 

Publications


Ngo Giang Huong N, Wittkop L (co-first author), Judd A, Reiss P, Goetghebuer T, Duiculescu D, Noguera-Julian A, Marczynska M, Giacquinto C, Ene L, Ramos JT, Cellerai C, Klimkait T, Brichard B, Valerius N, Sabin C, Teira T, Obel N, Stephan C, de Wit S, Thorne C, Gibb D, Schwimmer C, Athena Campbell M, Pillay D, Lallemant M. Prevalence and effect of pre-existing drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project. Submitted to the BMC Infectious Diseases 2016 2016 Nov 8;16(1):654.

Wittkop L. Endstage liver disease in HIV-infection: an avoidable burden? Editorial commentary CID 2016 Nov 1;63(9):1168-1170

Klein, M, Rockstroh J, Wittkop L. Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection. Curr Opin HIV AIDS 2016 Sep;11(5):521-526.

Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaître H, Boué F, Valantin MA, Dabis F, Salmon D, Wittkop L. All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 – HEPAVIH cohort. Clin Infect Dis. 2016 Sep 15;63(6):763-70.

P Duffau, L Wittkop (co-first author), E Lazaro, F Le Marec, C Cognet, P Blanco, J-F Moreau, F-A Dauchy, C Cazanave, M-A Vandenhende, F Bonnet, R Thiebaut, I Pellegrin for the ANRS CO3 Aquitaine cohort study group. Association of Immune-activation and -senescence Markers With non AIDS defining Comorbidities in HIV suppressed Patients. AIDS. 2015 Sep 10;29(14):1821-30.

Wittkop L, Bitard J, Lazaro E, Neau D, Bonnet F, Mercie P, Dupon M, Hessamfar M, Ventura M, Malvy D, Dabis F, Pellegrin JL, Moreau JF, Thiébaut R, Pellegrin I; for the Groupe d’Epidémiologie Clinique du SIDA en Aquitaine. Effect of Cytomegalovirus-Induced Immune Response, Self Antigen-Induced Immune Response, and Microbial Translocation on Chronic Immune Activation in Successfully Treated HIV Type 1-Infected Patients: The ANRS CO3 Aquitaine Cohort. J Infect Dis. 2013 Feb;207(4):622-627.

Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G; EuroCoord-CHAIN study group. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011 May;11(5):363-71.

 

 

partenaires

logo_ISPED logo_SFR-santepublique-societe logo_CHU-Bordeaux logo_Institut-Bergonie logo_INRIA logo_ANRS logo_HONcode